Biological
Poliovirus Vaccine, Inactivated clinical trials
Also written JNJ-64152348.
- studies test it
- 26
- open now
- 2
- in phase 3
- 8
- first study started
- 2007
Keep track of what changes. Save the Poliovirus Vaccine, Inactivated studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
26 studies that test it; most in 2017 (7)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 3 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 7 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 3 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 2
- Phase 3
- 8
- Phase 4
- 13
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 12
GlaxoSmithKline (5) · Sinovac Biotech Co., Ltd (3) · Fidec Corporation (3) · Janssen Vaccines & Prevention B.V. (2) · Jiangsu Province Centers for Disease Control and Prevention (2) · Aga Khan University (2) · International Centre for Diarrhoeal Disease Research, Bangladesh (2) · Beijing Minhai Biotechnology Co., Ltd (1)
Often tested with
Tested in the same studies.
Poliovirus Vaccine, Oral (4) · Measles-Mumps-Rubella Vaccine (1) · RotaTeq (1) · 13-valent pneumococcal vaccine (1) · PHiD-CV vaccine (1) · Rabies virus strain PM-1503-3M antigen (propiolactone inactivated) (1) · Vaxigrip (1) · Vaccines, Combined (1)
Studies
Open first, then newest update. How each study uses Poliovirus Vaccine, Inactivated is read from its arms, and is right about nine times in ten.
Testing it · 26
- Phase IV Clinical Study of sIPV Administration in Adolescent and Adult PopulationsRecruitingPhase 4Sinovac Biotech Co., LtdNCT07354269Written as sIPV
- Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)Not yet recruitingPhase 4International Centre for Diarrhoeal Disease Research, BangladeshNCT06748612Written as Inactivated poliovirus vaccine (IPV)
- Booster Dose of sIPV Co-administered With MMR and HepA-I.CompletedPhase 4Sinovac Biotech Co., LtdNCT06442449Written as sIPV
- Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)CompletedPhase 3Beijing Minhai Biotechnology Co., LtdNCT07297186Written as sIPV
- A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese InfantsCompletedPhase 3GlaxoSmithKlineNCT06331156Written as IPV
- Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different ManufacturersCompletedPhase 4Sinovac Biotech Co., LtdNCT06346834Written as sIPV
- A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization ScheduleCompletedPhase 2Janssen Vaccines & Prevention B.V.NCT03566940Written as sIPV
- A First in Human Study to Assess the Safety, Tolerability and Immunogenicity of a Single Dose of a Trivalent Inactivated Poliovirus Vaccine Based on Sabin Strains (sIPV) Given Intramuscularly in Healthy AdultsCompletedPhase 1Janssen Vaccines & Prevention B.V.NCT03032588Written as sIPV
- Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)CompletedPhase 3Merck Sharp & Dohme LLCNCT04481191Written as IPV
- Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood VaccinesCompletedPhase 4Duke UniversityNCT03530124Written as IPV
- A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPVCompletedPhase 3Fidec CorporationNCT03239496Written as IPV
- Immunogenicity of Intramuscular and Intradermal IPVTerminatedPhase 4Centers for Disease Control and PreventionNCT04063150Written as IPV
- Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in BangladeshStatus unknownPhase 4International Centre for Diarrhoeal Disease Research, BangladeshNCT03890497Written as IPV
- Immunogenicity and Safety of Sabin-IPV Replacement VaccinationCompletedPhase 4China National Biotec Group Company LimitedNCT04051736Written as Inactivated Polio Vaccine
- Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib)CompletedPhase 1/2Jiangsu Province Centers for Disease Control and PreventionNCT04264546Written as sIPV
- Safety and Immunogenicity of a Sabin Inactivated Poliovirus VaccineCompletedPhase 1Jiangsu Province Centers for Disease Control and PreventionNCT04264598Written as sIPV
- Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ VaccineCompletedPhase 3GlaxoSmithKlineNCT01021293Written as Poliorix™
- Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same VaccinesCompletedPhase 3GlaxoSmithKlineNCT00547248Written as Poliorix
- Comparison of Immunity Following IPV Versus fIPV: a Community Based Randomized Controlled Trial in PakistanStatus unknownPhase 4Aga Khan UniversityNCT03286803Written as Inactivated Poliovirus vaccine
- Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in InfantsCompletedPhase 1GlaxoSmithKlineNCT00937404Written as Poliorix
See all 26 studies that test Poliovirus Vaccine, Inactivated →
Given in every arm · 5 — Poliovirus Vaccine, Inactivated is usual care beside what is tested
- Study of Concomitant Administration of the sIPV and DTaP or MMRNot yet recruitingPhase 4Institute of Medical Biology, Chinese Academy of Medical SciencesNCT06920069Written as sIPV
- Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate VaccineCompletedPhase 3GlaxoSmithKlineNCT00344318Written as Poliorix.
- Assessment of Community Transmission of Sabin Type 2 Virus in BangladeshStatus unknownPhase 3University of VirginiaNCT02477046Written as IPV
- Intestinal and Humoral Immunity of Sequential Polio Vaccination SchedulesCompletedPhase 4Centers for Disease Control and PreventionNCT02412514Written as IPV
- Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV VaccineStatus unknownPhase 4University of ChileNCT01841671Written as IPV
As the comparator · 9 — what is tested is compared with Poliovirus Vaccine, Inactivated
- Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina FasoCompletedPhase 2University of Maryland, BaltimoreNCT03614533Written as Inactivated Poliovirus Vaccine (IPV)
- An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural BangladeshActive, not recruitingPhase 4University of BergenNCT04998344Written as Inactivated polio vaccine
- Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMRStatus unknownPhase 4China National Biotec Group Company LimitedNCT04638985Written as sIPV
- Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepAStatus unknownPhase 4China National Biotec Group Company LimitedNCT04636827Written as sIPV
- Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy ToddlersCompletedPhase 2GlaxoSmithKlineNCT01106092Written as Poliorix™
- Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ VaccineCompletedPhase 3GlaxoSmithKlineNCT01086423Written as Poliorix™
- Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western KenyaWithdrawnPhase 2/3Centers for Disease Control and PreventionNCT01810731Written as Inactivated Polio Vaccine
- Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy AdultsCompletedPhase 1Pauline VerdijkNCT01708720Written as IPV
- Safety and Immunogenicity of a New Inactivated Poliovirus Vaccine in InfantsCompletedPhase 1/2Pauline VerdijkNCT01709071Written as IPV